{"id":75601,"date":"2025-12-15T15:22:09","date_gmt":"2025-12-15T15:22:09","guid":{"rendered":"https:\/\/www.europesays.com\/lv\/75601\/"},"modified":"2025-12-15T15:22:09","modified_gmt":"2025-12-15T15:22:09","slug":"antivakseri-tagad-dzili-nozelo-petijuma-atklata-sensacionala-informacija-par-covid-19-vakcinam","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/lv\/75601\/","title":{"rendered":"Antivakseri tagad dzi\u013ci no\u017e\u0113lo?! P\u0113t\u012bjum\u0101 atkl\u0101ta sensacion\u0101la inform\u0101cija par Covid-19 vakc\u012bn\u0101m"},"content":{"rendered":"

\" Ilustrat\u012bvs<\/p>\n

Ilustrat\u012bvs foto<\/p>\n

Foto. THOMAS KIENZLE \/ AFP\n<\/p>\n

16:17, 15. decembris 2025<\/p>\n

Pieaugu\u0161ajiem, kuri sa\u0146\u0113mu\u0161i vismaz vienu Covid-19 vakc\u012bnas devu, ir zem\u0101ks n\u0101ves risks neatkar\u012bgi no n\u0101ves iemesla, atkl\u0101jis Francij\u0101 veikts jauns p\u0113t\u012bjums.<\/a><\/p>\n

Las\u012bt\u0101kie
\n <\/p>\n

\"\"<\/p>\n

Vair\u0101ki kilogrami! Tepat, kaimi\u0146os, v\u0113stures entuziasti me\u017e\u0101 atrod 86 gadus sl\u0113ptus d\u0101rgumus<\/p>\n

<\/a><\/p>\n

\"\"<\/p>\n

\n Piecas lietas, kuras ka\u0137i dara katru dienu, ta\u010du uzskat\u012bs j\u016bs par liel\u0101kajiem ienaidniekiem, ja taj\u0101s iejauksieties\n <\/p>\n

<\/a><\/p>\n

\"\"<\/p>\n

\n \u201cEs eju pensij\u0101!\u201d V\u012brietis nop\u0113rk lietotu jaku un paliek bez v\u0101rdiem par to, ko atradis t\u0101s kabat\u0101\n <\/p>\n

<\/a>
\n Las\u012bt citas zi\u0146as<\/a><\/p>\n

Cilv\u0113kiem, kuri sa\u0146\u0113ma vismaz vienu mRNS Covid-19 vakc\u012bnas devu, bija zem\u0101ks mirst\u012bbas risks no jebk\u0101diem n\u0101ves c\u0113lo\u0146iem, sal\u012bdzinot ar nevakcin\u0113t\u0101m person\u0101m.<\/p>\n

Rezult\u0101ti liecina, ka \u0161\u012bs vakc\u012bnas, t\u0101lu no t\u0101, lai palielin\u0101tu ilgtermi\u0146a riskus, ir saist\u012btas ar samazin\u0101tu mirst\u012bbu \u010detru gadu period\u0101 \u2014 kop\u0161 vakcin\u0101cijas kulmin\u0101cijas 2021. gad\u0101.<\/p>\n

CITI \u0160OBR\u012aD LASA<\/p>\n

Eiropas Savien\u012bb\u0101 l\u012bdz 2023. gada febru\u0101rim tika ievad\u012btas vair\u0101k nek\u0101 976 miljoni Covid-19 vakc\u012bnu devu, liecina Eiropas Slim\u012bbu profilakses un kontroles centra (ECDC) dati, un programmas kop\u0161 t\u0101 laika ir turpin\u0101ju\u0161\u0101s ar desmitiem miljonu papildu balstvakcin\u0101cijas devu katr\u0101 sezon\u0101.<\/p>\n

P\u0113t\u012bjum\u0101, kur\u0101 tika analiz\u0113ti 28 miljoni Francijas pieaugu\u0161o vecum\u0101 no 18 l\u012bdz 59 gadiem, atkl\u0101ts, ka vakcin\u0113t\u0101m person\u0101m bija par 74 procentiem zem\u0101ks n\u0101ves risks no smagas Covid-19 saslim\u0161anas formas un par 25 procentiem zem\u0101ks kop\u0113j\u0101s mirst\u012bbas risks. <\/p>\n

P\u0113tnieki nor\u0101d\u012bja, ka zem\u0101kais mirst\u012bbas risks da\u013c\u0113ji skaidrojams ar sp\u0113c\u012bgu aizsardz\u012bbu pret smagu slim\u012bbas gaitu \u2014 vakcin\u0113ti pieaugu\u0161ie daudz ret\u0101k mira no infekcijas. Tika ar\u012b pie\u013cauts, ka maz\u0101ks ar ilgsto\u0161o Covid-19 saist\u012bto komplik\u0101ciju skaits var\u0113tu veicin\u0101t kop\u0113jo n\u0101ves gad\u012bjumu samazin\u0101\u0161anos.<\/p><\/blockquote>\n

P\u0113t\u012bjumu veica \u201cEpi-Phare\u201d \u2014 zin\u0101tnisko intere\u0161u grupa, kuru p\u0101rrauga Francijas Nacion\u0101l\u0101 z\u0101\u013cu un vesel\u012bbas produktu dro\u0161\u012bbas a\u0123ent\u016bra (ANSM) un Francijas Nacion\u0101lais vesel\u012bbas apdro\u0161in\u0101\u0161anas fonds. Komanda secin\u0101ja, ka c\u0113lo\u0146sakar\u012bba starp mRNS vakcin\u0101ciju un p\u0101rm\u0113r\u012bgu ilgtermi\u0146a mirst\u012bbu tagad \u0161\u0137iet \u013coti maz ticama.<\/p>\n

Izmantojot Francijas Nacion\u0101l\u0101s vesel\u012bbas datu sist\u0113mas datus, p\u0113t\u012bjum\u0101 tika iek\u013cauti 22,7 miljoni cilv\u0113ku, kuri tika vakcin\u0113ti laik\u0101 no 2021. gada maija l\u012bdz oktobrim, un 5,9 miljoni nevakcin\u0113tu personu uz 2021. gada 1. novembri; vi\u0146i tika nov\u0113roti vid\u0113ji 45 m\u0113ne\u0161us.<\/p>\n

\u0160is p\u0113t\u012bjums ir l\u012bdz \u0161im liel\u0101kais, kas analiz\u0113 Covid-19 mRNS vakc\u012bnu ilgtermi\u0146a dro\u0161umu visp\u0101r\u0113j\u0101 pieaugu\u0161o popul\u0101cij\u0101.<\/p>\n

Dal\u012bbnieki nebija vec\u0101ki par 59 gadiem, t\u0101p\u0113c secin\u0101jumi tie\u0161i neattiecas uz vec\u0101ka gadag\u0101juma cilv\u0113kiem, kuriem ir visaugst\u0101kais Covid-19 risks.
\u010cetru gadu nov\u0113ro\u0161anas laik\u0101 vakcin\u0113to vid\u016b tika re\u0123istr\u0113ti 98 429 n\u0101ves gad\u012bjumi no visiem c\u0113lo\u0146iem (0,4 procenti), sal\u012bdzinot ar 32 662 gad\u012bjumiem (0,6 procenti) nevakcin\u0113to vid\u016b.<\/p>\n

Autori zi\u0146oja, ka netika konstat\u0113ts n\u0101ves gad\u012bjumu pieaugums no v\u0113\u017ea, sirds un asinsvadu slim\u012bb\u0101m, nelaimes gad\u012bjumiem vai jebkura cita noz\u012bm\u012bga iemesla; katr\u0101 kategorij\u0101 vakcin\u0113tajiem mirst\u012bbas r\u0101d\u012bt\u0101ji bija vien\u0101di vai zem\u0101ki nek\u0101 tiem, kuri palika nevakcin\u0113ti.<\/p>\n

T\u0113mas<\/p>\n

SAIST\u012aTIE RAKSTI<\/p>\n","protected":false},"excerpt":{"rendered":"Ilustrat\u012bvs foto Foto. THOMAS KIENZLE \/ AFP 16:17, 15. decembris 2025 Pieaugu\u0161ajiem, kuri sa\u0146\u0113mu\u0161i vismaz vienu Covid-19 vakc\u012bnas…\n","protected":false},"author":2,"featured_media":75602,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[23,57,28,29,32,33,22,30,31,35,39,38,36,37,34,40,20,26,27,24,25,54,55,56,21,58],"class_list":{"0":"post-75601","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-zinas-no-arvalstim","8":"tag-aktualitates","9":"tag-arvalstim","10":"tag-breaking-news","11":"tag-breakingnews","12":"tag-featured-news","13":"tag-featurednews","14":"tag-headlines","15":"tag-latest-news","16":"tag-latestnews","17":"tag-latvia","18":"tag-latvian","19":"tag-latviesu","20":"tag-latviesu-valoda","21":"tag-latviesuvaloda","22":"tag-latvija","23":"tag-lv","24":"tag-news","25":"tag-popularakas-zinas","26":"tag-popularakaszinas","27":"tag-top-stories","28":"tag-topstories","29":"tag-world","30":"tag-world-news","31":"tag-worldnews","32":"tag-zinas","33":"tag-zinas-no-arvalstim"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115724271382082638","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/75601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=75601"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/75601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/75602"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=75601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=75601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=75601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}